1. Home
  2. JJSF vs MIRM Comparison

JJSF vs MIRM Comparison

Compare JJSF & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JJSF
  • MIRM
  • Stock Information
  • Founded
  • JJSF 1971
  • MIRM 2018
  • Country
  • JJSF United States
  • MIRM United States
  • Employees
  • JJSF N/A
  • MIRM N/A
  • Industry
  • JJSF Specialty Foods
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • JJSF Consumer Staples
  • MIRM Health Care
  • Exchange
  • JJSF Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • JJSF 2.1B
  • MIRM 3.3B
  • IPO Year
  • JJSF N/A
  • MIRM 2019
  • Fundamental
  • Price
  • JJSF $103.00
  • MIRM $73.23
  • Analyst Decision
  • JJSF Buy
  • MIRM Strong Buy
  • Analyst Count
  • JJSF 2
  • MIRM 10
  • Target Price
  • JJSF $142.50
  • MIRM $74.20
  • AVG Volume (30 Days)
  • JJSF 123.3K
  • MIRM 699.8K
  • Earning Date
  • JJSF 11-12-2025
  • MIRM 11-11-2025
  • Dividend Yield
  • JJSF 3.02%
  • MIRM N/A
  • EPS Growth
  • JJSF N/A
  • MIRM N/A
  • EPS
  • JJSF 4.29
  • MIRM N/A
  • Revenue
  • JJSF $1,599,746,000.00
  • MIRM $429,161,000.00
  • Revenue This Year
  • JJSF $4.52
  • MIRM $53.08
  • Revenue Next Year
  • JJSF $2.86
  • MIRM $20.45
  • P/E Ratio
  • JJSF $24.11
  • MIRM N/A
  • Revenue Growth
  • JJSF 0.49
  • MIRM 62.33
  • 52 Week Low
  • JJSF $101.62
  • MIRM $36.86
  • 52 Week High
  • JJSF $180.80
  • MIRM $78.10
  • Technical
  • Relative Strength Index (RSI)
  • JJSF 51.84
  • MIRM 58.90
  • Support Level
  • JJSF $104.49
  • MIRM $73.35
  • Resistance Level
  • JJSF $108.56
  • MIRM $74.99
  • Average True Range (ATR)
  • JJSF 2.12
  • MIRM 2.33
  • MACD
  • JJSF -6.19
  • MIRM -0.93
  • Stochastic Oscillator
  • JJSF 90.41
  • MIRM 21.85

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: